Document D14npqRKKy2mV7kD0w7Jy2zo

C r 3M Spcei.ltyMattriah 3sMt PCaeunlteMrN 55144-1Ooo 651 733 1110 January 3,2003 Document Control mce @CO) Oflice of Pollution Prevention and ToxicS (OPPT) US Environmental Protection Agency EPAEast,Room6428 1201 Constitution Avenue,NW Washington,DC 20460 Attentiox Docket No.AR-226 andthe FYIDocket This continues3Ms voluntary submissionsof data o n p ~ m t a nseulfonatea and related compounds, as part of our ongoing dialogue with EPA regarding fluomhemi&. IncIuded in this submission are the following: `TdwmtanesulfonylFluoride (POSF),T-7661.2,Bactedal Reverse Mutation Test", Huntingdon Life Sciences Ltd., October 23,2002. `Tcrfluom~cnulfonyMl uoride (POSF), T-7661.3,In Yitro Mammalian Chromosome Aberration Tcst inHusnan Lymphocytq HuntingdonLife Sciences Ltd., October22, 2002 and Protocol. We will continue to provide information as it becomes available. Pleqm f-1 &ee to contact me if you have any questions. cc: Dr.CharlesAum Dr. Oscar Herixmdez Michael A4antom Director ofhhmental,Health SafetyandRegulatory~ SpecialtyMateriatSMarkets 3M Center, Building 236-1B-10 St.P@MN 55144 651-733-6374 (phone) 651-733- 1958 (fax) E-mail:masantoro@mmm.com